Filter
2362
Filtered Results: 2362
Text search:
regimens
Featured
Recommendations
243
New Publications
599
Language
Document type
No document type
1439
Guidelines
373
Studies & Reports
303
Manuals
83
Strategic & Response Plan
52
Fact sheets
50
Training Material
27
Infographics
18
Situation Updates
9
Resource Platforms
4
Brochures
2
Online Courses
2
Countries / Regions
India
136
South Africa
74
Global
72
Kenya
56
Ethiopia
54
Tanzania
52
Western and Central Europe
43
Uganda
38
Nigeria
37
Zambia
37
Nepal
34
Latin America and the Carribbean
34
Africa
32
Malawi
31
Eastern Europe
31
Rwanda
29
Ghana
24
Philippines
24
Liberia
24
Ukraine
23
Bangladesh
21
Namibia
20
Indonesia
19
Zimbabwe
18
Myanmar / Burma
18
Asia
17
South–East Asia Region
17
Cambodia
16
Sierra Leone
14
Mozambique
14
Russia
14
Botswana
12
Lesotho
11
Senegal
10
Colombia
9
West and Central Africa
9
Brazil
9
East and Southern Africa
8
Eswatini/ Swaziland
8
Thailand
7
Cameroon
7
Syria
7
Germany
7
Congo, Democratic Republic of
7
Middle East and North Africa
7
Venezuela
6
Paraguay
6
Georgia
6
Tajikistan
5
Albania
5
Haiti
5
Western Pacific Region
5
Argentina
5
South Sudan
5
Pakistan
5
Benin
4
USA
4
Vietnam
4
China
3
Estonia
3
Afghanistan
3
Peru
3
Eastern Europe and Central Asia
3
Jamaica
3
Bhutan
3
Somalia
3
North Macedonia
2
Timor Leste/ East Timor
2
Laos
2
Burkina Faso
2
Guinea
2
Jordan
2
North America
2
Bolivia
2
Sri Lanka
2
Sudan
2
Romania
2
Iraq
2
North Korea
1
El Salvador
1
Serbia
1
Gambia
1
Kazakhstan
1
Chile
1
Iran
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Morocco
1
Armenia
1
Saudi Arabia
1
Denmark
1
Tunisia
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Papua New Guinea
1
Moldova
1
Egypt
1
Yemen
1
Greece
1
Central African Republic
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
837
Clinical Guidelines
340
Public Health
111
Women & Child Health
101
Capacity Building
51
Key Resources
33
Pharmacy & Technologies
19
Toolboxes
HIV
410
TB
385
NTDs
111
COVID-19
93
AMR
80
Pharmacy
63
NCDs
60
Mental Health
58
Caregiver
45
Ebola & Marburg
34
Rapid Response
29
Refugee
27
Conflict
19
Cholera
13
Polio
13
Disability
11
Planetary Health
10
Health Financing Toolbox
9
Natural Hazards
7
Specific Hazards
5
Global Health Education
5
Social Ethics
4
Malaria
4
Zika
2
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
COVID-19: Guidelines for case-finding, diagnosis, management and public health response in South Africa
recommended
The information contained in this document, be it guidelines, recommendations, diagnostic algorithms or treatment regimens, are offered in this document in the public interest. To the best of the knowledge of the guideline writing team, the information contained in these guidelines is correct. Imple...
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...
• diagnosis of HIV
• update on the initiation of ART<...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implementation considerations for different regimens for eli...
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
The study on single-dose cholera vaccine in Zambia evaluates the effectiveness of using a single dose of the oral cholera vaccine (OCV) during a 2016 outbreak in Lusaka. Due to limited vaccine supply, authorities opted for a one-dose emergency campaign instead of the usual two-dose regimen. A matche...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care.
The aim of the present study was to predict which patients with severe or difficult-to-treat asthma are at highest risk for healthcare utilisation can be predicted so as to optimise clinical management. Data were derived from 2,821 adults with asthma enrolled in The Epidemiology and Natural History ...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been compromised by gaps...
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
